NCT06692452 2026-04-01
Tazemetostat Plus CHOP in 1L T-cell Lymphoma
Dana-Farber Cancer Institute
Phase 2 Withdrawn
Dana-Farber Cancer Institute
Fondazione Italiana Linfomi - ETS
N.N. Petrov National Medical Research Center of Oncology
New York Medical College